To investigate neuropathological processes involved in HIV infection, a longitudinal analysis of central nervous system (CNS) changes was performed using the SIV-infected macaque model. Five animals were studied during the early phase and 13 during the asymptomatic and symptomatic phases. Histopathological analyses were performed on one cerebral ®xed hemisphere whereas on the other frozen hemisphere in situ hybridisation, immunohistochemistry and RT ± PCR were performed. Viral load was quanti®ed by in situ hybridisation, CD4 and CD8 T cell in®ltration by immunohistochemistry and mRNA cytokine expression (IL1b, IL2, IL6, TNFa, IFNg and TGF-b1) by semiquantitative RT ± PCR. As reported for HIV-infected humans, the neuropathological analysis of SIV infected animals revealed four distinct lesion pro®les: minimal changes, early encephalitis, leukoencephalopathy and encephalitis. No relationship was found between neuropathological ®ndings, numbers of SIV replicating cells and T cell in®ltration. CNS infection was found to be an early event characterised by glial activation, an increase in the level of IL1b, TNFa and IL6 mRNA expression. During the asymptomatic and symptomatic phases, IL6 and IL1b mRNAs increase coincided with gliosis and the development of myelin lesions. The absence of relationship between neuropathological ®ndings and viral load suggests that cerebral lesions are caused by an indirect mechanism. In¯ammatory cytokine pattern associated with severe lesions show the key role of glial activation in the SIV neuropathological process.
Introduction
Neuropathology associated with HIV (human immunode®ciency virus) infection is one of the major complications of the AIDS (acquired immunode®-ciency syndrome). The virological and cellular mechanisms by which HIV infection induces motor and cognitive disorders remain unknown Dubois-Dalcq et al., 1990; Lazarini et al, 1997; Sharer, 1992; Spencer and Price, 1992) . HIV neuropathogenesis is dif®cult to investigate because of the limited information provided by longitudinal analysis of cerebrospinal¯uid (CSF) alterations and post-mortem studies.
Consequently, animal models are essential for studies of HIV neuropathology (Fox et al, 1997; Persidsky et al, 1995; Petry and Luke, 1997; Vitkovic et al, 1995; Zinc et al, 1998) . SIV causes encephalopathy in the macaque similar to the neurological lesions in patients with AIDS and does so with comparable frequency (Chakrabarti et al, 1991; Ringler et al, 1988; Sasseville and Lackner, 1997; Sharer, 1994; Simon et al, 1992) . In both HIVinfected human and SIV-infected macaque, the infection of the brain occurs early (Chakrabarti et al, 1991; Grant et al, 1987; Gray et al, 1992) and only monocyte-derived cells produce virus (Chakrabarti et al, 1991; Koenig et al, 1986; Lackner et al, 1991; Unger et al, 1992; Vazeux et al, 1987) . It would be valuable to know whether a relatively small number of infected cells can cause severe neuropathology and whether this neuropathology is directly due to the virus itself or is induced by the host's response to infection. There is some in vitro evidence that microglial cells release various products which are toxic for brain cells, such as cytokines and neurotoxins. The AIDS dementia complex may result from the activity of one or more of these products (Benveniste, 1994; Gendelman et al, 1997; McEntee et al, 1992; Merrill and Martinez-Maza, 1993 ; Nottet et al, 1997; Persidsky et al, 1997; Vitkovic et al, 1994; Wilt et al, 1995) . To determine whether the effects of the virus are direct or indirect, we conducted a longitudinal analysis of the CNS in SIV infected animals. We followed the development of neuropathology, the viral load, and the number of in®ltrating T lymphocytes. Indeed, T lymphocytes have been reported to be present in the CNS of patients who died during either pre-AIDS or AIDS stages of the disease (Bell et al, 1993) . Finally, we analysed cytokine expression to identify the cells involved in the neuropathological changes.
Results
Acute infection Neuropathology and numbers of CNS infected cells Five animals were infected intravenously (i.v.) with the pathogenic isolate SIVmac 251 and sacri®ced at 4, 7, and 14 days post-inoculation (p.i.). The neuropathological lesions (Table 1) were generally similar in the different regions examined although the median region displayed more severe lesions at each time point. In all animals, there were minimal changes, with astrogliosis, leptomeningeal and perivascular in®ltrates, rare multinucleated giant cells (MGC), microglial nodules and white matter pallor. The severity of these lesions varied between the animals. The replicating SIV cells were enu-merated by in situ hybridisation (Figure 1) . The virus was detected in all infected monkeys and was thus present in the brain as early as 4 days p.i. For this animal, the infected cells were only observed near blood vessels. Infected and productive cells were observed in all brain zones examined. The number of virus-replicating cells was low in all animals (5mean of ®ve positive cells/50 mm 2 ), and there was no obvious difference between the different time points. The density of infected cells was higher in the median zone than the other zones in all animals. They were found scattered throughout the brain, mostly in the white matter and fewer in the grey matter. Immunohistochemistry was used to reveal CD4 + and CD8 + T lymphocytes. These cells were found in all the zones studied in the CNS from the earliest time point (4 days), see Table 1 . There were more CD8 + cells than CD4 + cells. There was no detectable association between the number of infected cells, the count of T lymphocytes and neuropathology.
Cytokine production in the CNS To determine which cell type is involved in these pathological processes, semi-quantitative RT ± PCR was used to assay cytokine mRNA (IL1b, IL2, IL6, TNFa, IFNg, and TGF-b1) in the frontal and median area of the animals. During the early phase, the IL6 mRNA expressed transiently in the two animals sacri®ced on day 7 p.i. (Figure 1 ). IL1b mRNA was constitutively produced, but was slightly more abundant on day 7 p.i. The level of TNFa mRNA was higher 7 days p.i. and TGF-b1 mRNA was detected at a constant level throughout the early phase. Despite the presence of lymphocytes neither IL2 mRNA nor IFNg mRNA was detected in any animal sacri®ced during the early phase.
Asymptomatic and symptomatic phases Neuropathology and numbers of CNS infected cells Infected animals were sacri®ced during the asymptomatic phase after predetermined periods of infection, or as soon as the ®rst symptoms of the pre-AIDS stage appeared. The animals were classi®ed according to length of infection before sacri®ce and to neuropathological characteristics. The neuropathological analysis revealed various different patterns of lesions as reported for HIV-infected humans: minimal changes, early encephalitis, leukoencephalopathy, and encephalitis. The neuropathology is described in Table 2 for animals presenting minimal changes and in Table 3 for animals presenting early encephalitis, leukoencephalopathy and encephalitis. The monkey sacri®ced on day 30 had developed early encephalitis with microglial nodules in the frontal zone and myelin pallor in all zones examined. The animals with leukoencephalopathy presented marked white matter pallor, MGC, and leptomeningeal in®ltrates. Encephalitis was manifest as numerous MGC, MGC nodules and substantial perivascular and leptomeningeal in®ltrates. The replicating SIV cells were enumerated by in situ hybridisation ( Figure 2 ). The distribution of SIV-infected cells was the same as during the early stage. The viral load did not appear to be related to the duration of infection, but was higher than during the early phase. There was no apparent relationship between the viral load in any of the three zones and the lesions observed. T lymphocytes, mostly CD8 + and fewer CD4 + , were present in the brains of all infected animals, but there was no relationship between the lesions, the viral load and CD4 + and CD8 + in®ltration in animals presenting minimal changes ( Table 2 ). The animal sacri®ced on day 227 presented an encephalitis, a high viral load and the CD8 + count higher in the three areas tested (112 to 145 cells/50 mm 2 ). There was a large number of T lymphocytes in the median zone of the brain from the animal presenting early encephalitis (Table 3 ). The various haematological clinical markers assessed (T4/T8 ratio, antibody titers and antigenemia) did not associate with the brain viral load or the pattern of CNS lesions (Tables  2 and 3 ). Nevertheless the absence of antibodies and the presence of antigenemia were associated with the two encephalities.
Cytokine production in the CNS As described for early stages, mRNA cytokines were quanti®ed by RT ± PCR. The animals were classi®ed according to length of infection before sacri®ce and to neuropathological analysis. The ®ndings are depicted in Figure 3 . Animals presenting minimal changes had similar levels of IL1b and TGF-b1 mRNAs but divergent levels of IL6 and TNFa mRNAs. However, there was no apparent relationship with the lesions observed. In both animals with leukoencephalopathy, IL1b, IL6, and TGF-b1 mRNAs were abundant, particularly in the frontal zone, despite a low level of TNFa mRNA. The animals suffering encephalitis had high levels of IL1b, IL6, TNFa and TGF-b1 mRNAs, although this overexpression was less pronounced in the animal sacri®ced on day 227 p.i. The comparison between animals presenting severe neuropathology (encephalitis and leukoencephalopathy) and uninfected animals shows a signi®cant difference (P=0.05) for IL1b in the frontal area and IL6 in the frontal and median areas. As during the early phase, IL2 and IFNg mRNAs were not detected in any of the animals.
Discussion
The genesis of lesion during AIDS encephalopathy remains poorly understood. This is due to the paucity of human sample during the course of the disease. SIVmac 251 causes cerebral lesions in the CNS of rhesus macaque similar to those of HIVinfected human (Chakrabarti et al, 1991; Gray et al, Figure 1 Quanti®cation by in situ hybridisation of SIV infected cells and cytokine mRNA expression, in brains of monkeys inoculated i.v. with SIVmac 251 and sacri®ced at 4, 7 and 14 days post-inoculation. SIV infected cells were counted on six or more complete sections performed in the frontal ( ) and median ( ) area and the cerebellum ( ). The results are expressed as the mean by 50 mm 2 . Quanti®cation by RT ± PCR of mRNA cytokines (IL1b, IL6, TNFa, TGF-b1) in the frontal ( ) and median ( ) area of the same brains. The means of four non-infected animals are represented by arrows. IL2 and IFNg mRNA cytokines were also investigated but were not detected in all these brains. The legends of neuropathology and status are given in Table 2 . The animals were classi®ed according to neuropathological ®ndings, early encephalitis (EE), leukoencephalopathy (L) and encephalitis (E) and length of infection before sacri®ce, expressed as days post inoculation.
Figure 2
Productive infected cells in brain of SIV infected monkeys during the asymptomatic and symptomatic stages. The monkeys were sacri®ced during the asymptomatic stage at predetermined times or at ®rst preAIDS symptoms appearance. The animals were classi®ed according to length of infection before sacri®ce, expressed as days post inoculation (DPI), and to ®ndings of neuropathological analysis (NA): minimal changes (MC), early encephalitis (EE), leukoencephalopathy (L) and encephalitis (E). The SIV infected cells were detected by in situ hybridisation and counted in the frontal ( ) and median ( ) area and the cerebellum ( ). The results are expressed as the mean by 50 mm 2 .
Viral load and neuropathology D Boche et al brain parenchyma, minimal changes, particularly leptomeninges in®ltrates, microglial nodules, gliosis and white matter pallor could be visualised in the three areas studied. These results show that a low viral load can generate lesions more and less severe according to monkeys. These features observed in macaques infected by SIV are indistinguishable from those described for early HIVseropositive patients who died from non-natural causes in comparison with seronegative individuals (Gray et al, 1992 Bell et al, 1993) . Both CD4 + and CD8 + T lymphocyte in®ltration was observed in all infected animals, but the CD8 + cell count was much higher than the CD4 + cell count. There was no relationship between the viral load, the neuropathology and the T lymphocyte count. The amounts of the proin¯ammatory cytokine (IL1b, IL6 and TNFa) mRNAs were high 7 days p.i. and this was associated with the appearance of infected cells in the CNS and a diffuse astrocyte and microglia gliosis. As the major source of TNFa is activated macrophages, the production of TNFa 7 days p.i. re¯ects mainly the transition from monocytes to activated macrophages in the CNS. Our in vivo data and that of others corroborate the involvement of monocytes/macrophages in the early CNS infection (Chakrabarti et al, 1991; Lane et al, 1996; Zhu et al., 1995) . The IL1b and IL6 production may be a consequence of macrophage in®ltration or re¯ect glial cell activation. These two cytokines are both synthesised by macrophages, astrocytes and microglial cells (Morganti-Kossmann et al, 1992; Woodroofe, 1995) .
As noted above for the early phase, during the asymptomatic and symptomatic stage, there was no relationship between the neuropathology, the viral load and the CD8 + T lymphocyte count. The dissociation between the low viral load and the severity of the lesions was clear in animals presenting leukoencephalopathy. Nevertheless for the encephalitis case sacri®ced at 227 days p.i., the severe neuropathology was associated with a high viral load and numerous CD8 + T cells. High IL1b, IL6 and TGF-b1 mRNA levels were associated with severe lesions. The role of TGF-b1 is unclear. We do not know whether it has bene®cial or detrimental effects on the brain. The increased level could be a consequence of the terminal phase rather than a cause of the severe lesions of the AIDS phase (Morganti-Kossmann et al, 1992; Wyss-Coray et al, 1997). The myelin lesions were always associated with IL1b and IL6 production, nevertheless some animals presented a small increase without myelin lesions. This dissociation between the virus replicate cells, the cerebral lesions and cytokine expression indicates that there is individual variability in susceptibility to the virus. During the primary phase, the IL1b mRNA level and IL6 mRNA production were associated with microglia and astrocyte activation. This activation was visualised as gliosis without any severe lesion. The relationship with myelin lesions appeared only during the asymptomatic and symptomatic phases. These observations suggest that prolonged and constant activation of microglia and astrocytes is necessary for the development of myelin lesions. In transgenic mice, overproducing IL6 in astrocytes, the microglia was activated with a pattern that is suggestive of a major contribution of IL6 to the development of these lesions (Campbell et al, 1993; Gold et al, 1996) . It must be noted that in the two animals developing encephalitis both had antigenemia, lack of antibodies and high viral load in the brain. As previously described, there is an association between the development of encephalitis and rapid disease progression (Westmoreland et al, 1998) .
mRNA for IL2 and IFNg cytokines, both produced by T lymphocytes, were not detected in the brains of any of the animals examined. Furthermore, the absence of relationship between the lymphocyte Figure 3 Quanti®cation by RT ± PCR of mRNA cytokines (IL1b, IL6, TNFa, TGF-b1) in the frontal ( ) and the median ( ) area of the same brains that Figure 2 . The animals were classi®ed according to length of infection before sacri®ce, expressed as days post inoculation (DPI), and to ®ndings of neuropathological analysis (NA): minimal changes (MC), early encephalitis (EE), leukoencephalopathy (L) and encephalitis (E). The means of four non-infected animals are represented by arrows. IL2 and IFNg mRNA cytokines were also investigated but were not detected.
counts and the pattern of lesions argues against a role for lymphocytes for the development of the lesions. The contribution of these cells to the infection process, either neuroinvasion or progression of the disease, is unknown. The non-detection of these two cytokines could be due to the local environment of the CNS that exerting a complex negative-regulatory effect on brain recruited T cells, as shown in the Sindbis virus encephalitis model (Irani et al, 1997) . However, T cells are a minority cell type in the CNS, and the failure to detect IFNg mRNA may have been due to the detection threshold of the technique used. Thus we can not totally exclude the possibility that T lymphocytes contribute to the neuropathological changes, as suggested by Merrill (Merrill and Martinez-Maza, 1993) and An .
In conclusion, our longitudinal study of SIVinfected macaques shows that the virus penetrates into the CNS via the macrophage early during the infection. The early events were characterised by glial activation, an increase in the level of IL1b mRNA and local production of IL6 mRNA. The absence of relationships between the lesions observed and the number of infected cells con®rms the hypothesis in favour of cerebral damages mediated by indirect mechanism in SIV and HIV infections. The association between severe lesions and IL1b and IL6 levels, cytokines produced mainly by glial cells, suggests that these lesions were generated in susceptible animals presenting a persistent glial activation in response to SIV production.
Materials and methods

Animals and SIV infection
Prior to inoculation, adult rhesus monkeys (Macaca mulatta) were demonstrated to be seronegative for STLV-1, SRV-1 (type D retrovirus), herpes B virus, and SIVmac. Animals were infected with the pathogenic SIVmac 251 isolate provided by R Desrosiers (New England Regional Primate Research Center, Southborough, MA, USA) (Daniel et al, 1985) . Monkeys were infected by intravenous (i.v.) injection of 3610 3 (TCID), tissue culture infectious doses and killed at various times postinoculation (p.i.), from 4 days p.i. to the terminal stage of infection. Four uninfected animals were used as negative controls.
Serologic assays
Antigenemia was detected by measurement of SIV p27 gag antigen in monkey sera, using a SIVmac antigen capture ELISA test (Coulter). The antibody response to SIV was monitored with an HIV-2 ELISA test that contain viral antigens mix. The result is positive if the difference between densitometry with antigen and densitometry without antigen is higher than 0.3 (Elavia-II, Sano®-Pasteur).
Histopathology
Complete necropsy and histopathological examinations were performed, and a systematic study was carried out on the brain. For each animal, one cerebral hemisphere, half of the cerebellum and half of the brainstem were ®xed in formalin, embedded in paraf®n and celloidin. Sections were stained by haematoxylin and eosin, Loyez stain for myelin and Bodian silver impregnation combined with Luxol fast blue. Myelin pallor was judged on celloidin embedded sections. Histopathological analysis was performed on seven different brain sections: between A35 and A25 for the frontal area, between A15 and A5 for the median area (basal ganglia, thalamus, ventral nucleus) and the cerebellum (Szabo and Cowan, 1983) . Findings in infected monkeys were compared with those in uninfected animals. The animals were classi®ed according to the human pattern. Minimal changes include essentially gliosis, leptomeningeal in®ltrates and microglial nodules. HIV leukoencephalopathy is de®ned as a diffuse damage to the white matter including myelin loss, reactive astrocytosis, macrophages and MGC. HIV encephalitis is de®ned by multiple disseminated foci composed of microglia, macrophages and MGC; these lesions may include reactive gliosis, lymphocytic in®ltrates and myelin loss. Early encephalitis is less severe and occurs during the early stage of infection.
Quanti®cation of virus load by in situ hybridisation
In situ hybridisation was performed on the other half sample, cooled in liquid nitrogen and stored at 7808C. Hybridisation was performed as previously described (Chakrabarti et al, 1991) with RNA probes derived from a fragment of the SIVmac-142 plasmid clone (Chakrabarti et al, 1987) inserted into thè Bluescript' vector (Vector Cloning System). An RNA antisense probe nef was generated from the T7 promoter by in vitro transcription. The same hybridisation technique was used for positive controls (SIV-infected cultured cells spotted onto slides coated with 3-aminopropyltriethoxysilane (Sigma)), and negative controls (brain tissue from uninfected animals). Infected cells were counted on a minimum 18 complete sections and the sum was divided by the entire surface analysed. The results expressed as a mean values per 50 mm 2 . The sections were from the same area investigated histopathologically.
Quanti®cation of T cells by immunohistochemistry
Frozen tissue sections cut on a cryostat were investigated by immunohistochemistry techniques. Leu2a (anti-CD8, Becton Dickinson), OKT4 (anti-CD4, Ortho-Diagnostic), Kim7 (anti-CD68, Behring) antibodies were used to detect T lymphocytes. CD8 and CD4 T cells were respectively characterised as CD8 + and CD4 + CD68 7 T cells. Stained cells were counted in infected brains and compared to those in Quanti®cation of cytokine mRNA expression by semiquantitative RT ± PCR Total RNA was extracted from brain tissues after lysed in RNAzol (Bioprobe, France). RNA was quanti®ed by measuring the optical density at 260 and 280 nm. cDNA was synthesised from oligodT(16)-primed RNA by incubation with M-MLV RT SuperScript' (Gibco BRL) and dNTPs (Pharmacia). Each cDNA sample was subjected to PCR ampli®ca-tion with cytokine gene-speci®c primers: (interleukin (IL)-1b, IL2, IL6, Interferon (IFN)-g, Tumor Necrosis Factor (TNF)-a (Villinger et al (1993) , and Transforming Growth Factor (TGF)-b1 (Clontech).
PCR products were analysed on 1.8% agarose gels. The amount of DNA in each band was determined by densitometry (number of pixels), using Optilab TM / Pro 2.5 (Graftek, Mirmande-France) and normalised for the amount of mRNA encoding glyceraldehyde-3-phosphate dehydrogenase (GADPH), detected in the sample. The amount of cDNA and thus cytokine mRNA is reported as the cytokine mRNA/GADPH mRNA ratio.
